Pavan Cheruvu, Bitterroot Bio CEO
Scoop: As Sio closes, former CEO from ‘vant exit finds himself at helm of Irv Weissman stealth biotech
Stanford stem cell luminary Irv Weissman is building a new biotech around the ‘don’t eat me’ signal CD47 — but instead of cancer, the new biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
